10:39 AM EST, 02/05/2025 (MT Newswires) -- Embraer ( ERJ ) said Wednesday it launched a cash tender offer to buy outstanding senior unsecured guaranteed notes due 2027 and 2028 issued by Embraer Netherlands Finance B.V. The offer covers all $522 million of 5.400% notes due 2027 and up to $150 million of 6.950% notes due 2028, the company said....

10:43 AM EST, 02/05/2025 (MT Newswires) -- SmartCentres Real Estate Investment Trust (SRU-UN.TO) said Wednesday it has closed its $300 million debenture offering. The Series AB 4.737% debentures will mature on Aug. 5, 2031. Proceeds will be used to refinance existing debt, including the repayment of its $160 million Series N senior unsecured debentures due Feb. 6, 2025, the repayment...

10:43 AM EST, 02/05/2025 (MT Newswires) -- Acrivon Therapeutics ( ACRV ) said Wednesday the US Food and Drug Administration has granted its ACR-368 OncoSignature Assay Breakthrough Device designation. The assay is designed to identify endometrial cancer patients who are likely to respond to the company's ACR-368 treatment, the company said. The designation accelerates the product's development, assessment, and review...

10:39 AM EST, 02/05/2025 (MT Newswires) -- Indaptus Therapeutics ( INDP ) said Wednesday it received clinical trial authorization from Health Canada for its Decoy20 drug candidate. The approval allows expansion of the company's ongoing US phase 1 study, INDP-D101, in patients with locally advanced or metastatic solid tumors to Canadian sites, according to Indaptus. The company said it will...